Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum levels of recently discovered circulating forms of adhesion molecules, ICAM-1 and L-selectin, were found to be elevated in
IDDM
patients and in subjects at risk for developing
IDDM
compared with 100 normal, nondiabetic blood donors. Both adhesion molecules were determined by sandwich ELISA. Serum concentrations of either clCAM-1 or cL-selectin were > 2SD of normal mean in 10 of 14 recent-onset
IDDM
patients (P < 0.05). Serum levels of clCAM-1 and cL-selectin did not correlate. In first-degree relatives, elevated adhesion molecule levels were observed in the 6 ICA+ individuals and in the ICA- individuals all (n = 14) with a genetic risk of
IDDM
(sharing HLA-DR3 and/or-
DR4
with the diabetic relative) but not in the HLA-DR3- and/or -
DR4
- relatives (n = 13). We conclude that elevated clCAM-1 and cL-selectin levels occur independently of ICA status and probably reflect ongoing immune processes in recent-onset
IDDM
patients and first-degree relatives at risk for
IDDM
.
...
PMID:Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. 128 Feb 39
Genetic control of
insulin dependent diabetes mellitus
(
IDDM
) is mainly dependent on HLA genes in the major histocompatibility complex (MHC). The participation of TAP1 and TAP2 genes, located in the MHC region and coding for antigenic peptide transporters, was investigated in 116
IDDM
patients and 98 normal controls using oligotyping after DNA amplification. The TAP2-B allele had a dominant protective effect, additive to that of the DR2 haplotype but antagonist to the susceptibility associated with the DR3 and/or
DR4
haplotypes. The TAP2-A allele, in the homozygous state, had a predisposing effect. TAP1 allelic distribution did not differ among
IDDM
patients and controls. These data argue in favour of the role of peptide transporter gene in diabetogenesis.
...
PMID:TAP1 and TAP2 transporter genes and predisposition to insulin dependent diabetes mellitus. 130 Feb 36
In this study we report, for the first time, the molecular analysis of HLA-DR and DQ gene frequencies in a large cohort of well-characterized type 1 (insulin-dependent) diabetes mellitus (
IDDM
) patients (n = 72), and ethnically matched controls (n = 59) collected in sub-Saharan Africa. High molecular mass DNA was prepared and analysed in Southern blots and by oligonucleotide typing. We have shown a strong positive association between
IDDM
and the Asp 57- DQB1 allele *0201 (DQw2). A rare
DR4
, DQw2 haplotype was also identified at high frequency in the
IDDM
cohort. We can now confirm that the association between Asp 57- DQB1 alleles and
IDDM
, previously reported in ethnically diverse cohorts collected in Western Europe, North America, and South Asia, is also present in an
IDDM
cohort collected in Africa.
...
PMID:Identification of genetic susceptibility loci for insulin-dependent diabetes in Sudan. 135 6
To acquire more information on the controversial question of a possible association between rheumatoid arthritis (RA) and
insulin dependent diabetes mellitus
we searched for
insulin dependent diabetes mellitus
among patients hospitalized due to RA in 2 rheumatism hospitals in Finland. Nine subjects with
insulin dependent diabetes mellitus
were found among an annual number of 1460 patients admitted to one of the hospitals due to RA. These figures give a frequency of
insulin dependent diabetes mellitus
in patients with RA of 0.6% (95% confidence interval 0.2-1.0%), which does not exceed the prevalence of
insulin dependent diabetes mellitus
among the middle aged population of Finland in general (0.5-0.6%). Accordingly, no overrepresentation of homozygosity for HLA-DR4 was found among the total number of 25 patients with RA as well as
insulin dependent diabetes mellitus
, though the opposite might be expected as these diseases have a common
DR4
association--RA with
DR4
and DR1 and
insulin dependent diabetes mellitus
with
DR4
and DR3. Instead, an increased frequency of DR1 (p less than 0.0002) and the antigen combination DR1/4 (p less than 0.01) was found in the subjects with both RA and
insulin dependent diabetes mellitus
compared with the subjects with
insulin dependent diabetes mellitus
alone.
...
PMID:No association between rheumatoid arthritis and insulin dependent diabetes mellitus: an epidemiologic and immunogenetic study. 135 69
The genes located between class II and class I HLA genes including polymorphic tumour necrosis factor (TNF) genes may contribute to the disease susceptibility in
IDDM
. Restriction fragment polymorphisms of the TNF-beta gene have been found to be fixed in the major
IDDM
susceptibility haplotypes, the B62,
DR4
haplotype being associated with the 10.5-kb fragment and the B8,DR3 haplotype with a 5.5-kb fragment. We studied this TNF polymorphism in a sample of diabetic families. In all
IDDM
-associated haplotypes (n = 129) the 5.5-kb allele was more frequent than in haplotypes found only in healthy family members (n = 112) (58.1% versus 40.2%, P < 0.01). Among
IDDM
haplotypes the B62,
DR4
haplotype was characterized by the 10.5-kb TNF fragment, whereas two other common Finnish
IDDM
-associated
DR4
haplotypes--A24,B39,
DR4
and A2,B56,
DR4
--had the 5.5-kb TNF fragment. Both
IDDM
-associated and non-associated DR3 positive haplotypes were linked to the 5.5-kb fragment. The distribution of various combinations of TNF alleles in
IDDM
probands (n = 63) did not differ from that expected according to the Hardy-Weinberg distribution. Our results indicate that the 10.5-kb allele of TNF-beta gene as such is not a risk factor contributing to
DR4
/DQ8-associated susceptibility. Alternatively, there may be heterogeneity in pathogenetic effector mechanisms.
...
PMID:Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group. 136 Oct 76
Type 1 diabetes mellitus
is known to be a heterogenous disease which is frequently complicated with other autoimmune thyroid diseases (AITD). The present study was designed to investigate the clinical characteristics and HLA antigens in Japanese Type 1 diabetic patients with AITD. Subjects were 25 Type 1 diabetic patients with AITD (13 Graves' disease and 12 Hashimoto's thyroiditis) and 32 Type 1 diabetic patients without AITD. Compared with Type 1 diabetic patients without AITD, age at onset of diabetes was later and positive ICA persisted much longer in the diabetic patients with AITD. Compared with normal controls, DR9 was increased in the patients with AITD, while
DR4
was increased in those without AITD. Type 1 diabetic patients with AITD were characterized by the late onset of diabetes, persistent ICA and increased association with DR9. These results suggest that immunological and genetic heterogeneity may exist within Japanese Type 1 diabetic patients.
...
PMID:Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune thyroid disease in Japan. 142 12
We have used the XI Histocompatibility Workshop sequence-specific oligonucleotide probes to determine the DRB1, DQA1 and DQB1 genotypes by dot-blot hybridization of polymerase chain reaction (pcr)-amplified material from a homogenous black population in Zimbabwe. The
DR4
subtype DRB1*0405, the DR3 subtype DRB1*0301, DQB1*0201 and DQB1*0302 and DQA1*0301 and DQA1*0501 were significantly increased in the
IDDM
group compared to the controls, whereas DRB1*11, DQB1*0602 and DQA1*0102 were significantly decreased. Taken together, the data show that susceptibility and resistance to
IDDM
are associated both with particular haplotypes and DQA1-DQB1 heterodimers without one or other being overriding.
...
PMID:Distribution of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe. 144 May 68
To determine whether genetic markers can improve the predictive value of islet cell antibodies for development of Type 1 (insulin-dependent) diabetes mellitus, 536 siblings aged 2-29 years were consecutively enrolled in a 8-year prospective survey. The risk of developing diabetes was estimated, using life-table methods, by years of follow-up and age, according to genetic factors (shared HLA-haplotypes, DR antigens, C4 allotypes) and islet cell antibody status. Fifteen siblings (2.8%) developed Type 1 diabetes during the study period (risk 4.4% after 8 years, 4% by age 22 years). DR3,4 heterozygosity identified higher risk (16% after 8 years, 12% by age 22 years, p less than 10(-5)) than HLA-identity (10% and 7%, respectively, p less than 0.01); risks for DR3 or
DR4
positive and for haplo-identical siblings were low (4%, 3% and 4.4%, respectively, NS). C4BQO also conferred significant risk (11% vs 3% in non-C4BQO siblings, p less than 0.01). The predictive value of genetic markers alone was poor (12% for DR3,4, 7% for HLA-identity, 9% for C4BQO) compared with that of islet cell antibody levels greater than 4
Juvenile Diabetes
Foundation units (41%, risk 56% after 8 years, p less than 10(-7)). HLA markers significantly contributed to risk prediction in combination with islet cell antibodies: islet cell antibody-positive DR3,4+ subjects had the highest risk (70% after 8 years, predictive value 58%, p less than 10(-7)) compared with islet cell antibody-positive DR3,4- (37% and 20%, respectively) and islet cell antibody-negative DR3,4+ (5% and 3.6%, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study. 145 52
Major determinants of susceptibility to Type 1 (insulin-dependent) diabetes (
IDDM
) have been mapped to the HLA complex, near to or identical with genes encoding class II molecules. The association of
IDDM
with HLA-DR3 and/or
DR4
antigens and the highest risk for DR3/4 heterozygotes suggest a synergistic effect of the two haplotypes. The characterization at the molecular level of the class II region has provided evidence that DQ rather than DR determinants may primarily influence the disease. In caucasians the susceptibility strongly correlates with the absence of aspartic acid at position 57 on the DQ beta chain and/or the presence of arginine at position 52 on the DQ alpha chain. The formation of a putative DQ susceptibility molecule (DQ alpha Arg52+, DQ beta Asp57-) accounts best for the disease associations when trans-complementation between alpha and beta chains encoded by different haplotypes is postulated to explain the excess of heterozygotes. Observations in other populations and in animal models indicate, however, that other residues on DQ alpha and beta chains, other class II (DR beta) molecules and non-HLA linked genes also contribute to the susceptibility. The mechanism(s) by which susceptibility determinants influence
IDDM
is not known. It is probably in relation with the role of class II molecules in the antigen presentation to T lymphocytes.
...
PMID:[The role of the HLA system in the genetics of Type I diabetes mellitus]. 145 12
There is a polygenic component to rheumatoid arthritis (RA) in addition to the known association with HLA-DR4. It has previously been shown in another autoimmune disease (
type I diabetes mellitus
) that a gene on chromosome 11p can act with HLA-DR4 to enhance susceptibility (relative risk 5-6). It is therefore possible that this locus may also affect the development of RA. Genotype frequencies at this locus, defined by a dimorphic Fok 1 restriction site, were compared in 139 healthy controls and 213 patients with classical/definite RA. In contrast with diabetes there was no increase in genotypes lacking the Fok 1 site, either in the rheumatoid group overall (125/211 compared with 86/139 controls) or in the
DR4
positive rheumatoid group (76/140 compared with controls). These results indicate that the interaction between
DR4
and a locus on chromosome 11p is not common to all
DR4
associated autoimmune diseases.
...
PMID:Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis? 146 4
1
2
3
4
5
6
7
8
9
10
Next >>